Studies related to HDL-C and Ashwagandha

Effects Of Withania Somnifera In Patients Of Schizophrenia: A Randomized, Double Blind, Placebo Controlled Pilot Trial Study

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 25
Sex Both Genders
Notes for this study:
Supplementation of 400mg of ashwagandha thrice daily for the course of one month in adults on medication and who also had metabolic syndrome noted that supplementation was able to reduce triglycerides (12%) and blood glucose (13%) with no apparent influence on HDL-C; there was no adverse interaction between ashwagandha and the medications noted.

Full details on all 4 studies are available to Examine memberstry free for 7-days.

Already a member? Login now to access.